Latest News

Education Drives Success in Atopic Dermatitis Treatment
Education Drives Success in Atopic Dermatitis Treatment

February 11th 2025

A recent expert discussion highlighted the importance of long-term planning, including when and how to adjust or transition therapies.

Developing Personalized Approaches for Atopic Dermatitis Treatment
Developing Personalized Approaches for Atopic Dermatitis Treatment

February 10th 2025

Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD

February 10th 2025

How Emerging Therapies Are Changing the AD Treatment Landscape
How Emerging Therapies Are Changing the AD Treatment Landscape

February 8th 2025

What’s Next for Topical JAK Inhibitors?
What’s Next for Topical JAK Inhibitors?

February 7th 2025

Latest CME Events & Activities

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

View More

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

View More

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Revolutionizing Atopic Dermatitis (RAD) Conference 2025

June 6-7, 2025

Register Now!

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

More News

© 2025 MJH Life Sciences

All rights reserved.